Private company

ONCOSEC MEDICAL Inc

ONCOSEC MEDICAL Inc is an American pharmaceutical preparations company based in Ewing.2

Last updated Oct 20, 2026.

Overview

-$34.2MNet income, fiscal 20223
  • IndustryPharmaceutical Preparations2
  • HeadquartersSan Diego, United States2
  • Incorporated inNV4
  • Business address820 Bear Tavern Road, Ewing, Nj 086284
  • Filer categoryNon-accelerated filer, Smaller reporting company4
  • Legal formCorporation2
  • LEI529900NA4JNULYG7UU402
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered address50 WEST LIBERTY STREET SUITE 880, 89501 Reno, United States2
  • Registered withBusiness Center (Secretary of State), NV200810214482

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-558.6%Return on equity3
0.15×Debt to equity3
-$32.4MFree cash flow3

Financial statements

Operating income567893-$37.0M in 2022+74% since 2015
-$60.0M-$40.0M-$20.0M02015: -$21.2M-$21.2M20152016: -$26.9M-$26.9M2016+27%2017: -$21.6M-$21.6M2017−20%2018: -$36.1M-$36.1M2018+67%2019: -$30.4M-$30.4M2019−16%2020: -$43.4M-$43.4M2020+43%2021: -$48.4M-$48.4M2021+11%2022: -$37.0M-$37.0M2022−23%
Net income51067893-$34.2M in 2022+61% since 2015
-$60.0M-$40.0M-$20.0M02015: -$21.2M-$21.2M20152016: -$26.9M-$26.9M2016+27%2017: -$21.4M-$21.4M2017−20%2018: -$39.1M-$39.1M2018+82%2019: -$30.3M-$30.3M2019−23%2020: -$42.3M-$42.3M2020+40%2021: -$45.2M-$45.2M2021+7%2022: -$34.2M-$34.2M2022−24%
Fiscal year20152016201720182019202020212022
Research and development$18.4M8$25.1M9$34.1M3$25.8M3
Operating income-$21.2M5-$26.9M5-$21.6M6-$36.1M7-$30.4M8-$43.4M9-$48.4M3-$37.0M3
Interest$3.8K8$5.1K9$15.9K3$20.9K3
Income before tax-$37.5M3
Income tax$2.0K5$2.5K10$1.4K6$6807$1.3K8-$872.6K9-$2.4M3-$3.3M3
Net income-$21.2M5-$26.9M10-$21.4M6-$39.1M7-$30.3M8-$42.3M9-$45.2M3-$34.2M3
Earnings per share-$1.373-$0.873
Shares (weighted, basic)39.3M shares3

Compare ONCOSEC MEDICAL Inc with another company

Corporate structure

ONCOSEC MEDICAL Inc sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of ONCOSEC MEDICAL Inc

  • SZOP MULTISTRAT LP Filed SC 13G/A on ONCOSEC MEDICAL Inc, latest Feb 13, 2024
  • INTRACOASTAL CAPITAL, LLC Filed SC 13G on ONCOSEC MEDICAL Inc, latest May 25, 2023
  • SZOP Multistrat Management LLC Filed SC 13G on ONCOSEC MEDICAL Inc, latest May 19, 2023
  • Lind Global Fund II LP Filed SC 13G on ONCOSEC MEDICAL Inc, latest Apr 17, 2023
  • Avidity Partners Management LP Filed SC 13G/A on ONCOSEC MEDICAL Inc, latest Feb 14, 2023 (2 filings since Feb 14, 2022)
  • ONCOSEC MEDICAL Inc San Diego, California, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What ONCOSEC MEDICAL Inc reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$2.5M3 Jul 31, 2022$2.3M3 Jul 31, 2021+10.3%
Accumulated depreciation$1.6M3 Jul 31, 2022$1.4M3 Jul 31, 2021+13.7%
Property and equipment, net$978.6K3 Jul 31, 2022$928.8K3 Jul 31, 2021+5.4%
Operating-lease assets (leased space)$4.7M3 Jul 31, 2022$5.4M3 Jul 31, 2021−14.3%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$6.7M3 Oct 17, 2022$46.0M3 Jul 31, 2021−85.4%

Intangibles and goodwill

ItemLatestA year beforeChange
Finite-lived intangibles, gross$495.0K3 Jul 31, 2022$495.0K3 Jul 31, 20210%
Accumulated amortization$116.5K3 Jul 31, 2022$46.6K3 Jul 31, 2021+150.0%
Finite-lived intangibles, net$378.5K3 Jul 31, 2022$448.4K3 Jul 31, 2021−15.6%

Leadership

Who has led ONCOSEC MEDICAL Inc, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Punit Dhillon2011–2017
  2. Brian A. Leuthner2021
  3. Robert H. Arch2022

President

  1. Punit Dhillon2011–2018
  2. Robert H. Arch2022

Chief financial officer

  1. Veronica Vallejo2013–2015
  2. Richard B. Slansky2015–2018
  3. Sara Bonstein2018–2020
  4. George Chi2022

Chief operating officer

  1. Sara Bonstein2018–2020
  2. Kellie Malloy Foerter2020
  3. Brian A. Leuthner2021
201520202025
Board members and other officers (18)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • DirectorJoon R Kim named Apr 24, 2023 to May 26, 202341
  • DirectorKevin R Smith named Apr 24, 2023 to May 26, 202341
  • DirectorStephany R Foster named Apr 24, 2023 to May 26, 202341

Former names

  • NetVentory Solutions, Inc.Sep 3, 2008 to Feb 4, 20114

Timeline

  1. Jun 22, 20238-K Listing notice or transfer42
  2. Jun 14, 20238-K Executive or director change43
  3. Jun 14, 20238-K Bankruptcy or receivership; Debt or obligation accelerated; Executive or director change44
  4. Jun 2, 20238-K Listing notice or transfer45
  5. May 18, 20238-K Entered a material agreement; Unregistered sale of shares; Other events46
  6. May 16, 20238-K Other events47
  7. Apr 27, 20238-K Other events48
  8. Apr 11, 20238-K Entered a material agreement; Unregistered sale of shares; Other events49
  9. Apr 3, 20238-K Other events50
  10. Feb 22, 20238-K Other events51
  11. Jan 4, 20238-K Bylaws or fiscal year changed; Shareholder vote52
  12. Dec 28, 20228-K Listing notice or transfer53
  13. May 3, 2022New chief executive Robert H. Arch becomes CEO14
  14. Jun 29, 2021New chief executive Brian A. Leuthner becomes CEO15
  15. Mar 21, 2011New chief executive Punit Dhillon becomes CEO16

Filings

94 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 35 major events, 12 insider forms, 6 large holders, 2 private raises, 32 other. The latest 20:

  1. Feb 13, 2024SC 13G/A EDGAR
  2. Jun 22, 20238-K EDGAR
  3. Jun 14, 20238-K EDGAR
  4. Jun 14, 20238-K EDGAR
  5. Jun 2, 20238-K EDGAR
  6. May 26, 2023D EDGAR
  7. May 25, 2023SC 13G SCHEDULE 13G EDGAR
  8. May 19, 2023SC 13G EDGAR
  9. May 18, 20238-K EDGAR
  10. May 18, 2023424B5 EDGAR
  11. May 16, 20238-K EDGAR
  12. Apr 27, 20238-K EDGAR
  13. Apr 24, 2023D EDGAR
  14. Apr 17, 2023SC 13G EDGAR
  15. Apr 11, 20238-K EDGAR
  16. Apr 11, 2023424B5 EDGAR
  17. Apr 10, 2023RW EDGAR
  18. Apr 3, 2023S-1/A EDGAR
  19. Apr 3, 20238-K EDGAR
  20. Mar 28, 2023S-1 EDGAR

The 94 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

6 open-market trades by officers, directors and large owners since October 2021: 0 buys and 6 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Feb 9, 2023DelAversano Robert JVP, FinanceSale40$1.37$55Form 4
Nov 4, 2022DelAversano Robert JVP, FinanceSale283$0.37$105Form 4
Aug 5, 2022DelAversano Robert JVP, FinanceSale284$0.71$202Form 4
May 6, 2022DelAversano Robert JVP, FinanceSale274$0.83$227Form 4
Feb 9, 2022DelAversano Robert JVP, FinanceSale409$0.88$360Form 4
Nov 1, 2021DelAversano Robert JVP, FinanceSale343$1.75$600Form 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. May 16, 2023Filed a private offering of securities Form D: 7 investors so far Form D
  2. Apr 11, 2023Filed a private offering of securities Form D: 7 investors so far Form D

SEC filer profile

How ONCOSEC MEDICAL Inc is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARONCOSEC MEDICAL Inc1
  • CIK0001444307
  • Employer ID (EIN)98-05732521
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inNevada1
  • Fiscal year endsJuly 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address820 Bear Tavern Road, Ewing, NJ 086281
  • Phone(858) 210-73331
  • Shares outstanding2,971,246 as of Mar 13, 202312
  • Public float$21.0M as of Jan 31, 20223
  • On EDGAR sinceSep 3, 20081
  • Filings795 in all: 4 (169), 8-K (147), DEFA14A (48), 10-Q (44), DFAN14A (42), 3 (31), CORRESP (26), UPLOAD (26)1
    All 51 form types

    SC 13G/A (25), 424B5 (21), 424B3 (19), EFFECT (18), SC 13G (18), S-1/A (15), 10-K (14), S-8 (14), DEF 14A (13), POS AM (11), S-1 (9), 424B4 (8), SC 13D/A (8), PRE 14A (6), 10-K/A (5), 8-K/A (5), D (5), 4/A (4), NT 10-Q (4), S-3 (4), CT ORDER (3), PRRN14A (3), S-3/A (3), SC TO-C (3), 3/A (2), NT 10-K (2), PRER14A (2), RW (2), SC 13D (2), 10-Q/A (1), 25-NSE (1), 8-A12B (1), 8-A12G (1), AW (1), CERTNAS (1), DEFC14A (1), DEFN14A (1), DEFR14A (1), POS EX (1), PREC14A (1), S-3MEF (1), SC TO-I (1), SC TO-I/A (1)

  • Latest filingsAnnual report (10-K) Oct 31, 2022
    Quarterly report (10-Q) Mar 14, 2023
    Proxy statement (DEF 14A) Dec 12, 2022
    Latest 8-K (8-K) Jun 22, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
    SEC EDGAROther events
  48. 48
    SEC EDGAROther events
  49. 49
  50. 50
    SEC EDGAROther events
  51. 51
    SEC EDGAROther events
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58